These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19424994)

  • 21. Practical Bayesian design and analysis for drug and device clinical trials.
    Hobbs BP; Carlin BP
    J Biopharm Stat; 2008; 18(1):54-80. PubMed ID: 18161542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.
    Pradelli L; Iannazzo S; Zaniolo O
    Am J Cardiovasc Drugs; 2009; 9(6):383-92. PubMed ID: 19929036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Economic evaluation of the use of diclofenac/misoprostol in the treatment of osteoarticular diseases].
    Soto Alvarez J
    An Med Interna; 2000 Sep; 17(9):477-84. PubMed ID: 11100534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the Bayesian dynamic survival model in medicine.
    He J; McGee DL; Niu X
    Stat Med; 2010 Feb; 29(3):347-60. PubMed ID: 20014356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hierarchical Bayesian estimates of distributed MEG sources: theoretical aspects and comparison of variational and MCMC methods.
    Nummenmaa A; Auranen T; Hämäläinen MS; Jääskeläinen IP; Lampinen J; Sams M; Vehtari A
    Neuroimage; 2007 Apr; 35(2):669-85. PubMed ID: 17300961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An approximate Bayesian risk-analysis for the gastro-intestinal safety of ibuprofen.
    Wang J; Donnan PT; MacDonald TM
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):695-701. PubMed ID: 12512246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Bayesian approach to parameter estimation in HIV dynamical models.
    Putter H; Heisterkamp SH; Lange JM; de Wolf F
    Stat Med; 2002 Aug; 21(15):2199-214. PubMed ID: 12210633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An economic approach to health care.
    Homik JE; Suarez-Almazor M
    Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):203-18. PubMed ID: 15121040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian estimation of cost-effectiveness: an importance-sampling approach.
    Heitjan DF; Li H
    Health Econ; 2004 Feb; 13(2):191-8. PubMed ID: 14737756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.
    Sadatsafavi M; Bansback N; Zafari Z; Najafzadeh M; Marra C
    Value Health; 2013; 16(2):438-48. PubMed ID: 23538197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
    Cooper NJ; Sutton AJ; Abrams KR
    Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework.
    Briggs AH; Ades AE; Price MJ
    Med Decis Making; 2003; 23(4):341-50. PubMed ID: 12926584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Bayesian Markov Chain Monte Carlo methods to model cost-of-illness data.
    Cooper NJ; Sutton AJ; Mugford M; Abrams KR
    Med Decis Making; 2003; 23(1):38-53. PubMed ID: 12583454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Bayesian model averaging approach with non-informative priors for cost-effectiveness analyses.
    Conigliani C
    Stat Med; 2010 Jul; 29(16):1696-709. PubMed ID: 20572119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Bayesian approach to stochastic cost-effectiveness analysis.
    Briggs AH
    Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian approaches to random-effects meta-analysis: a comparative study.
    Smith TC; Spiegelhalter DJ; Thomas A
    Stat Med; 1995 Dec; 14(24):2685-99. PubMed ID: 8619108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis.
    Ades AE; Claxton K; Sculpher M
    Health Econ; 2006 Apr; 15(4):373-81. PubMed ID: 16389628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease.
    Haeussler K; den Hout AV; Baio G
    BMC Med Res Methodol; 2018 Aug; 18(1):82. PubMed ID: 30068316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network meta-analysis with competing risk outcomes.
    Ades AE; Mavranezouli I; Dias S; Welton NJ; Whittington C; Kendall T
    Value Health; 2010 Dec; 13(8):976-83. PubMed ID: 20825617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.